SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.900-4.3%Nov 6 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
HardToFind
mattstat
To: HardToFind who wrote (11454)12/14/2018 11:15:06 AM
From: drkaz2 Recommendations  Read Replies (2) of 12871
 
IMO - there is no good reason to buy any new shares of NNVC unless and until they actually start toxicity testing AND actually obtain an unambiguous license agreement for the shingles-specific disease treatment.

Nobody in their right mind who's not a shady financer will put money into NNVC until those facts are remedied.

If they actually get those two things done THEN it might be a stock with some upside again.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext